Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

USA - NYSE:NYT - US6501111073 - Common Stock

59.24 USD
+0.31 (+0.53%)
Last: 9/15/2025, 8:24:06 PM
59.24 USD
0 (0%)
Pre-Market: 9/16/2025, 4:19:08 AM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to NYT. NYT was compared to 99 industry peers in the Media industry. NYT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NYT is not valued too expensively and it also shows a decent growth rate. This makes NYT very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NYT had positive earnings in the past year.
In the past year NYT had a positive cash flow from operations.
In the past 5 years NYT has always been profitable.
Each year in the past 5 years NYT had a positive operating cash flow.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of NYT (11.42%) is better than 93.94% of its industry peers.
NYT has a Return On Equity of 16.55%. This is amongst the best in the industry. NYT outperforms 85.86% of its industry peers.
NYT has a better Return On Invested Capital (14.36%) than 94.95% of its industry peers.
NYT had an Average Return On Invested Capital over the past 3 years of 11.43%. This is above the industry average of 8.87%.
The last Return On Invested Capital (14.36%) for NYT is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROIC 14.36%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 11.92%, NYT belongs to the best of the industry, outperforming 82.83% of the companies in the same industry.
NYT's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 15.50%, NYT belongs to the best of the industry, outperforming 80.81% of the companies in the same industry.
In the last couple of years the Operating Margin of NYT has grown nicely.
NYT has a Gross Margin (50.04%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NYT has declined.
Industry RankSector Rank
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NYT is still creating some value.
The number of shares outstanding for NYT has been reduced compared to 1 year ago.
The number of shares outstanding for NYT has been reduced compared to 5 years ago.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 9.42 indicates that NYT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.42, NYT belongs to the best of the industry, outperforming 91.92% of the companies in the same industry.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.42
ROIC/WACC1.65
WACC8.7%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.48 indicates that NYT should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.48, NYT is doing good in the industry, outperforming 60.61% of the companies in the same industry.
A Quick Ratio of 1.48 indicates that NYT should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.48, NYT is doing good in the industry, outperforming 61.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.40% over the past year.
NYT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.92% yearly.
Looking at the last year, NYT shows a small growth in Revenue. The Revenue has grown by 7.82% in the last year.
NYT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.37% yearly.
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%

3.2 Future

The Earnings Per Share is expected to grow by 13.13% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.49% on average over the next years.
EPS Next Y16.88%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
EPS Next 5Y13.13%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 26.45, the valuation of NYT can be described as expensive.
64.65% of the companies in the same industry are more expensive than NYT, based on the Price/Earnings ratio.
NYT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.25, which indicates a rather expensive current valuation of NYT.
The rest of the industry has a similar Price/Forward Earnings ratio as NYT.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, NYT is valued at the same level.
Industry RankSector Rank
PE 26.45
Fwd PE 23.25
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

NYT's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NYT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.19
EV/EBITDA 17.49
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NYT has an outstanding profitability rating, which may justify a higher PE ratio.
NYT's earnings are expected to grow with 12.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.57
PEG (5Y)1.56
EPS Next 2Y12.58%
EPS Next 3Y12.09%

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.23%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.58, NYT pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, NYT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.23%

5.2 History

The dividend of NYT is nicely growing with an annual growth rate of 21.48%!
NYT has paid a dividend for at least 10 years, which is a reliable track record.
NYT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.48%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

29.50% of the earnings are spent on dividend by NYT. This is a low number and sustainable payout ratio.
NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP29.5%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NEW YORK TIMES CO-A

NYSE:NYT (9/15/2025, 8:24:06 PM)

Premarket: 59.24 0 (0%)

59.24

+0.31 (+0.53%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners97.12%
Inst Owner Change-0.29%
Ins Owners0.62%
Ins Owner Change-0.15%
Market Cap9.65B
Analysts75
Price Target58.59 (-1.1%)
Short Float %6.58%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield 1.23%
Yearly Dividend0.5
Dividend Growth(5Y)21.48%
DP29.5%
Div Incr Years6
Div Non Decr Years11
Ex-Date07-09 2025-07-09 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.94%
Min EPS beat(2)15.73%
Max EPS beat(2)18.14%
EPS beat(4)4
Avg EPS beat(4)12.21%
Min EPS beat(4)6.49%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)19.88%
EPS beat(12)12
Avg EPS beat(12)28.39%
EPS beat(16)16
Avg EPS beat(16)25.56%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)1.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)1.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.34%
PT rev (1m)2.58%
PT rev (3m)0.57%
EPS NQ rev (1m)1.53%
EPS NQ rev (3m)9.21%
EPS NY rev (1m)5.89%
EPS NY rev (3m)6.02%
Revenue NQ rev (1m)0.64%
Revenue NQ rev (3m)0.97%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)1.26%
Valuation
Industry RankSector Rank
PE 26.45
Fwd PE 23.25
P/S 3.59
P/FCF 21.19
P/OCF 19.69
P/B 4.98
P/tB 7.52
EV/EBITDA 17.49
EPS(TTM)2.24
EY3.78%
EPS(NY)2.55
Fwd EY4.3%
FCF(TTM)2.8
FCFY4.72%
OCF(TTM)3.01
OCFY5.08%
SpS16.51
BVpS11.89
TBVpS7.88
PEG (NY)1.57
PEG (5Y)1.56
Profitability
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROCE 18.71%
ROIC 14.36%
ROICexc 18.96%
ROICexgc 30.93%
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
FCFM 16.93%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
ROICexc(3y)14.65%
ROICexc(5y)14.2%
ROICexgc(3y)25.48%
ROICexgc(5y)21.57%
ROCE(3y)14.89%
ROCE(5y)13.67%
ROICexcg growth 3Y17%
ROICexcg growth 5Y17.39%
ROICexc growth 3Y3.36%
ROICexc growth 5Y8.52%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score9
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.07%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 97.77%
Profit Quality 142.1%
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 9.42
F-Score9
WACC8.7%
ROIC/WACC1.65
Cap/Depr(3y)35.41%
Cap/Depr(5y)44.4%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.45%
Profit Quality(3y)113.54%
Profit Quality(5y)142.07%
High Growth Momentum
Growth
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
EPS Next Y16.88%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
EPS Next 5Y13.13%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%
EBIT growth 1Y22.62%
EBIT growth 3Y10.95%
EBIT growth 5Y15.46%
EBIT Next Year31.33%
EBIT Next 3Y16.76%
EBIT Next 5YN/A
FCF growth 1Y101.81%
FCF growth 3Y17.6%
FCF growth 5Y21.42%
OCF growth 1Y92.64%
OCF growth 3Y15.12%
OCF growth 5Y16.67%